Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review

1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • Eli Lilly and Co
  • GlaxoSmithKline Plc
  • MallInckrodt Plc
  • Merck & Co Inc
  • MORE
Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Johnson & Johnson (J&J) engages in the research and development, manufacture and sale of a range of healthcare products. Its primary focus is on the development of products related to human health and well-being. The company provides pharmaceuticals in immunology, cancer, neuroscience, infectious, cardiovascular and metabolic diseases areas; consumer products in baby care, oral care, beauty, over-the-counter (OTC) pharmaceutical, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopedic, surgery, diabetes care and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and consumer products through retail outlets and distributors. The company provides its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.

Johnson & Johnson Key Recent Developments

Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson
Feb 26, 2018: New Late-Breaking XARELTO (rivaroxaban) and INVOKANA (canagliflozin) Data to be Presented at the American College of Cardiology's Annual Scientific Session
Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results
Dec 13, 2017: Janssen and Leading Advocacy Organizations Introduce Cancer.com, a Customizable Online Destination for People Impacted by Cancer
Dec 05, 2017: Bioethics International Releases the "Good Pharma Scorecard" in BMJ Open, Ranking the Top 20 Largest Pharmaceutical Companies on Clinical Trial Transparency

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • Eli Lilly and Co
  • GlaxoSmithKline Plc
  • MallInckrodt Plc
  • Merck & Co Inc
  • MORE
Section 1 - About the Company
  • Johnson & Johnson - Key Facts
  • Johnson & Johnson - Key Employees
  • Johnson & Johnson - Key Employee Biographies
  • Johnson & Johnson - Major Products and Services
  • Johnson & Johnson - History
  • Johnson & Johnson - Company Statement
  • Johnson & Johnson - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Johnson & Johnson - Business Description
  • Business Segment: Consumer
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Medical Devices
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Pharmaceutical
  • Overview
  • Business Segment: Pharmaceuticals
  • Performance
  • Key Stats
  • Geographical Segment: Asia-Pacific, Africa
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: United States
  • Performance
  • Geographical Segment: Western Hemisphere excluding U.S.
  • Performance
  • R&D Overview
  • Johnson & Johnson - Corporate Strategy
  • Johnson & Johnson - SWOT Analysis
  • SWOT Analysis - Overview
  • Johnson & Johnson - Strengths
  • Johnson & Johnson - Weaknesses
  • Johnson & Johnson - Opportunities
  • Johnson & Johnson - Threats
  • Johnson & Johnson - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Johnson & Johnson, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson
  • Feb 26, 2018: New Late-Breaking XARELTO (rivaroxaban) and INVOKANA (canagliflozin) Data to be Presented at the American College of Cardiology's Annual Scientific Session
  • Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results
  • Dec 13, 2017: Janssen and Leading Advocacy Organizations Introduce Cancer.com, a Customizable Online Destination for People Impacted by Cancer
  • Dec 05, 2017: Bioethics International Releases the Good Pharma Scorecard in BMJ Open, Ranking the Top 20 Largest Pharmaceutical Companies on Clinical Trial Transparency
  • Nov 30, 2017: New HIV Prevention Trials Hold Promise for New Prevention Options for Women
  • Nov 16, 2017: Federal Jury Returns $247 Million Verdict in Defective Hip Implants Case
  • Nov 03, 2017: Johnson & Johnson wins Contract for Medical Surgical Products
  • Nov 01, 2017: Decision Diagnostics CEO Offers Primary Update on Legal Proceedings, Potential Outcomes, History, and Synopsis on Its Strategic Suit Against J&J
  • Oct 31, 2017: Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At ObesityWeek 2017
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Johnson & Johnson, Key Facts
  • Johnson & Johnson, Key Employees
  • Johnson & Johnson, Key Employee Biographies
  • Johnson & Johnson, Major Products and Services
  • Johnson & Johnson, History
  • Johnson & Johnson, Subsidiaries
  • Johnson & Johnson, Key Competitors
  • Johnson & Johnson, Ratios based on current share price
  • Johnson & Johnson, Annual Ratios
  • Johnson & Johnson, Annual Ratios
  • Johnson & Johnson, Annual Ratios
  • Johnson & Johnson, Interim Ratios
  • Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Johnson & Johnson, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Johnson & Johnson, Performance Chart (2013 - 2017)
  • Johnson & Johnson, Ratio Charts
  • Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Johnson & Johnson, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Stryker Corp
  • Sanofi
  • Sangui BioTech International Inc
  • Merck & Co Inc
  • Medtronic Plc
  • MallInckrodt Plc
  • L'Oreal SA
  • Kimberly-Clark Corporation
  • GlaxoSmithKline Plc
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Co
  • C. R. Bard Inc
  • Boston Scientific Corp
  • Beiersdorf AG
  • BABOR Cosmetics America Corp
  • Abbott Laboratories
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll